111 related articles for article (PubMed ID: 2177607)
21. Transcatheter hepatic subsegmental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas. Correlation between lipiodol accumulation pattern and local recurrence.
Murakami R; Yoshimatsu S; Yamashita Y; Sagara K; Arakawa A; Takahashi M
Acta Radiol; 1994 Nov; 35(6):576-80. PubMed ID: 7946681
[TBL] [Abstract][Full Text] [Related]
22. Iodized oil in the treatment of hepatocellular carcinoma.
Bhattacharya S; Novell JR; Winslet MC; Hobbs KE
Br J Surg; 1994 Nov; 81(11):1563-71. PubMed ID: 7827876
[TBL] [Abstract][Full Text] [Related]
23. Selective radionuclide localisation in primary liver tumours (pilot study).
Novell JR; Green AJ; Hilson AJ; Dusheiko G; Dick R; Hobbs KE
HPB Surg; 1994; 7(3):185-99; discussion 200. PubMed ID: 8155585
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma with skeletal metastasis: management with intraarterial radioactive iodine.
Cho YD; Yum HY; Park YH
J Belge Radiol; 1989 Aug; 72(4):267-71. PubMed ID: 2551883
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of hepatic artery injection of iodized oil and 131I-labeled iodized oil before the therapeutic decision in hepatocellular carcinoma.
Raoul JL; Duvauferrier R; Bretagne JF; Bourguet P; Heresbach D; Siproudhis L; Gosselin M
Scand J Gastroenterol; 1993 Mar; 28(3):217-23. PubMed ID: 7680489
[TBL] [Abstract][Full Text] [Related]
26. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant Intraarterial Lipiodol or ¹³¹I-Lipiodol After Curative Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial.
Dumortier J; Decullier E; Hilleret MN; Bin-Dorel S; Valette PJ; Boillot O; Partensky C; Letoublon C; Ducerf C; Leroy V; Vuillez JP; Borson-Chazot F
J Nucl Med; 2014 Jun; 55(6):877-83. PubMed ID: 24722530
[TBL] [Abstract][Full Text] [Related]
28. [Anticancer and side effect of arterial subsegmental chemoembolization using cisplatinum/pirarubicin lipiodol suspension (CTLS) for hepatocellular carcinoma].
Inoue H; Miyazono N; Kanetsuki I; Hori A; Tanaka D; Fukukura Y; Matsumoto Y; Nishida H; Ueno K; Nakajo M
Gan To Kagaku Ryoho; 1993 Oct; 20(13):1973-6. PubMed ID: 7692822
[TBL] [Abstract][Full Text] [Related]
29. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
[TBL] [Abstract][Full Text] [Related]
30. Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol.
Raoul JI; Bretagne JF; Caucanas JP; Pariente EA; Boyer J; Paris JC; Michel H; Bourguet P; Victor G; Therain F
Cancer; 1992 Jan; 69(2):346-52. PubMed ID: 1309429
[TBL] [Abstract][Full Text] [Related]
31. Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma.
Boucher E; Garin E; Guylligomarc'h A; Olivié D; Boudjema K; Raoul JL
Radiother Oncol; 2007 Jan; 82(1):76-82. PubMed ID: 17141900
[TBL] [Abstract][Full Text] [Related]
32. [Intra-arterial injection of cisplatin suspension in lipiodol (LPS) for the treatment of advanced hepatocellular carcinoma (stage IV)].
Shibata J; Kimura S; Nakashima M; Nakazono K; Miyase S; Sakai M; Fujiyama S; Sato T
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):357-64. PubMed ID: 2539053
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up.
Boucher E; Bouguen G; Garin E; Guillygomarch A; Boudjema K; Raoul JL
J Nucl Med; 2008 Mar; 49(3):362-6. PubMed ID: 18287267
[TBL] [Abstract][Full Text] [Related]
34. Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases.
Raoul JL; Bourguet P; Bretagne JF; Duvauferrier R; Coornaert S; Darnault P; Ramée A; Herry JY; Gastard J
Radiology; 1988 Aug; 168(2):541-5. PubMed ID: 2839866
[TBL] [Abstract][Full Text] [Related]
35. [Staging of hepatocellular carcinoma. Comparison of ultrasonography, computerized tomography, magnetic resonance, digital angiography, and computerized tomography with lipiodol].
Bartolozzi C; Lencioni R; Caramella D; Gibilisco G; Cioni R; Vignali C
Radiol Med; 1994 Oct; 88(4):429-36. PubMed ID: 7997616
[TBL] [Abstract][Full Text] [Related]
36. Thyroid uptake and radiation dose after (131)I-lipiodol treatment: is thyroid blocking by potassium iodide necessary?
Bacher K; Brans B; Monsieurs M; De Winter F; Dierckx RA; Thierens H
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1311-6. PubMed ID: 12271412
[TBL] [Abstract][Full Text] [Related]
37. 131-iodine Lipiodol therapy in hepatocellular carcinoma.
Raoul JL; Boucher E; Roland V; Garin E
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):348-55. PubMed ID: 19521315
[TBL] [Abstract][Full Text] [Related]
38. [Chemotherapy with Cisplatin-Phosphatidyl-choline-Lipiodol (CPL) suspension in unresectable hepatocellular carcinoma].
Aoki Y; Hirai K; Yamashita K; Noguchi H; Sakai T; Majima Y; Tanikawa K; Inoue H; Okano Y; Hitoshi T
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3066-9. PubMed ID: 2476969
[TBL] [Abstract][Full Text] [Related]
39. Interventional nuclear medicine in hepatocellular carcinoma and other tumours.
Buscombe JR
Nucl Med Commun; 2002 Sep; 23(9):837-41. PubMed ID: 12195086
[TBL] [Abstract][Full Text] [Related]
40. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support.
Raoul JL; Guyader D; Bretagne JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
J Nucl Med; 1994 Nov; 35(11):1782-7. PubMed ID: 7525901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
